A NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY

摘要

This present disclosure provides methods and compositions that can be used to quantify cfDNA in biofluids using a hybridization approach.